Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Claire Smits"'
Autor:
Parisa Asghari, Timothy J. Kieffer, Rich Wambolt, Michael F. Allard, Marjolaine Philit, James D. Johnson, Claire Smits, Lubos Bohunek, Edwin D.W. Moore, Kenneth R. Boheler, Edward G. Lakatta, Michael J. Bround
Publikováno v:
Cardiovascular research. 96(3)
Aims The molecular mechanisms controlling heart function and rhythmicity are incompletely understood. While it is widely accepted that the type 2 ryanodine receptor ( Ryr2 ) is the major Ca2+ release channel in excitation–contraction coupling, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22c691eb0bbf1c19576f2369d114116
https://pubmed.ncbi.nlm.nih.gov/22991333
https://pubmed.ncbi.nlm.nih.gov/22991333
Autor:
Alice J. Canaan, John Robert North, Ethan Sternberg, Anna M. Richter, Angela Cho, Claire Smits, Lina Hong, Ron Boch, David Dolphin, Ashok K. Jain
Publikováno v:
Photochemistry and photobiology. 82(1)
A newly synthesized diethylene glycol functionalized chlorin-type photosensitizer, lemuteporfin, was characterized for use in photodynamic therapy (PDT) in a panel of in vitro and in vivo test systems. The photosensitizer was highly potent, killing c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b713342f8e8c31ffcbc49d89b3bc7c8a
https://pubmed.ncbi.nlm.nih.gov/16097861
https://pubmed.ncbi.nlm.nih.gov/16097861
Publikováno v:
SPIE Proceedings.
The immune system is implicated in the mechanism of tumor destruction following photodynamic therapy (PDT).Several investigators have shown that immune stimulation can augment PDT. In this study, a single intratumoral injection ofENHANZYNTM adjuvant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::163ff7e3fa75f54c164d4c1f65c96d56
https://doi.org/10.1117/12.434705
https://doi.org/10.1117/12.434705
Autor:
Claire Smits, Martin Renke, Robert D. Bower, Julia G. Levy, Elizabeth Waterfield, Michele D. Gervais, Michael S. Stonefield
Publikováno v:
Photochemistry and photobiology. 60(4)
Benzoporphyrin derivative monoacid ring A (BPD-MA) is a chlorin-like photosensitizer currently in clinical trials for cancer and psoriasis. It has maximal absorption peaks at both 630 and 690 nm and can be activated at both these wavelengths. In vitr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8388450625e9f7b3288dfcb6436bbb
https://pubmed.ncbi.nlm.nih.gov/7991665
https://pubmed.ncbi.nlm.nih.gov/7991665
Autor:
Vincent Salvatori, Levy Julia G, Claire Smits, Luciann Hruza, Anna M. Richter, Harvey Lui, Elizabeth Waterfield, R. Rox Anderson
Publikováno v:
SPIE Proceedings.
Benzoporohyrin derivative monoacid ring A (BPD) is a lipophilic photosensitizer with a maximum absorption peak at 690 nm. When liposomally formulated, it distributes in human plasma almost exclusively to the lipoprotein fraction. In experimental anim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d45eb593f730e82dc4f44fd832c69c22
https://doi.org/10.1117/12.168659
https://doi.org/10.1117/12.168659
Publikováno v:
Immunopharmacology. 26(3)
This report describes the effects of the porphyrin photosensitizers, Photofrin ® and benzoporphyrin derivative (BPD) on the immunohematopoietic system of normal and immunosuppressed DBA/2 mice in the absence of activating light. Photofrin ® (10 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0ea729dec52f34ba0f84e220b85fea8
https://pubmed.ncbi.nlm.nih.gov/8288441
https://pubmed.ncbi.nlm.nih.gov/8288441